Peripheral nervous system involvement associated with COVID-19. A systematic review of literature
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0283827 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, 2023. Verfasst von Andreea-Raluca Hanganu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departament of Infectious Diseasese, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. Hauptthemen laut MEDLINE: COVID-19, Guillain-Barre Syndrome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
There is increasing evidence of both central and peripheral nervous system (PNS) involvement in COVID-19. We conducted this systematic literature review to investigate the characteristics, management and outcomes of patients with PNS, including the types and severity of cranial nerves (CN) involvement. We systematically searched on PubMed for studies reporting adult patients diagnosed with COVID-19 and PNS involvement until July 2021. From 1670 records, 225 articles matched the inclusion criteria, with a total of 1320 neurological events, in 1004 patients. There were 805 (61%) CN, 350 (26.5%) PNS, and 165 (12.5%) PNS plus CN events. The most frequently involved CN were the facial, vestibulo-cochlear and olfactory nerve in 27.3%, 25.4% and 16.1%, respectively. Guillain-Barre syndrome spectrum was identified in 84.2% of PNS events. We analysed 328 patients reported in 225 articles with CN, PNS, and PNS plus CN involvement. The patients with CN involvement were younger (mean age 46.2±17.1, p = .003), and were more frequently treated as outpatients (p < .001), mostly with glucocorticoids (p < .001). Patients that had PNS with or without CN involvement were more likely to be hospitalized (p < .001), and to receive intravenous immunoglobulins (p = .002) or plasma exchange (p = .002). Patients with CN, PNS, and PNS plus CN had severe COVID -19 disease in 24.8%, 37.3%, 34.9% respectively. The most common neurological outcome was mild/moderate sequelae in patients with CN, PNS, and PNS plus CN in 54.7%, 67.5% and 67.8% respectively (p = .1) and no significant difference was found between the three categories regarding death, disease severity, time from disease onset to neurological symptoms, lack of improvement and complete recovery. CN involvement was the most frequent PNS finding. All three categories of PNS involvement were rather associated to non-severe COVID-19 but it may be an important cause of hospitalization and post COVID-19 sequelae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departament of Infectious Diseasese, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
- Matei Balș National Institute of Infectious Diseases, Bucharest, Romania.
- Colentina Clinical Hospital, Internal Medicine Department, Bucharest, Romania.
- Department of Internal Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
- Department of Pathology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
- London School of Hygiene & Tropical Medicine, London, United Kingdom.
ORCID-Profile: Andreea-Raluca Hanganu, Cristian Băicuș
Zitieren
APA
Hanganu, A. R., Constantin, A., Moise, E. S., Niculae, C. M., Olaru, I. D., Băicuș, C., & Hristea, A. (2023). Peripheral nervous system involvement associated with COVID-19. A systematic review of literature. PLOS ONE. https://doi.org/10.1371/journal.pone.0283827
Vancouver
Hanganu AR, Constantin A, Moise ES, Niculae CM, Olaru ID, Băicuș C, et al. Peripheral nervous system involvement associated with COVID-19. A systematic review of literature. PLOS ONE. 2023. doi:10.1371/journal.pone.0283827
BibTeX
@article{Hanganu2023,
author = {Hanganu, Andreea-Raluca and Constantin, Alexandru and Moise, Elena-Sonia and Niculae, Cristian-Mihail and Olaru, Ioana Diana and Băicuș, Cristian and Hristea, Adriana},
title = {Peripheral nervous system involvement associated with COVID-19. A systematic review of literature},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0283827}
}
EUVIMED